findmyKOL
Clinical trialNCT02106884CompletedPhase 2Interventional

Quality of Life in Locally Advanced or Metastatic Pancreatic Cancer Treated With Gemcitabine and Nab-paclitaxel

SponsorUniversitaire Ziekenhuizen KU LeuvenEnrollment146Pancreatic Cancer
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

18 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Belgium
  • Olv Ziekenhuis Aalst

    Aalst, Belgium

  • Az Klina

    Brasschaat, Belgium

  • Az St Lucas

    Bruges, Belgium

  • Cliniques Universitaires St Luc

    Brussels, Belgium

  • Ulb Hôpital Erasme

    Brussels, Belgium

  • Chu de Charleroi

    Charleroi, Belgium

  • Uz Antwerpen

    Edegem, Belgium

  • Az Maria Middelares

    Ghent, Belgium

  • Uz Gent

    Ghent, Belgium

  • Uz Leuven

    Leuven, Belgium

  • Heilig Hartziekenhuis Lier

    Lier, Belgium

  • Chc St Joseph

    Liège, Belgium

  • Chr Citadelle

    Liège, Belgium

  • Chu Sart-Tilman

    Liège, Belgium

  • Az Sint Maarten

    Mechelen, Belgium

  • Clinique St Elisabeth

    Namur, Belgium

  • Az Delta

    Roeselare, Belgium

  • Az Turnhout

    Turnhout, Belgium

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

Gemcitabine →Paclitaxel →
Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
30 Apr 2014
Primary completion
29 Apr 2019
Completion
29 Apr 2019
Last update posted
6 Nov 2019
Registered enrollment
146
Registry id
NCT02106884

Cross-registrations

EU-CTR / CTIS (EudraCT)2013-004101-75
clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.